All lobbying filings
MANATT, PHELPS, AND PHILLIPS
Lobbying for DENALI THERAPEUTICS · Biopharmaceutical Company
Filing
Registration
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 14, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California
Lobbying activity
1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development